PMA device
Flow Re-Direction Endoluminal Device (FRED®) System
MicroVention, Inc. · Intracranial Aneurysm Flow Diverter (OUT, Class III) · First FDA decision Dec 16, 2019, newest Nov 2, 2025Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
8
Naming "Flow Re-Direction Endoluminal"
MAUDE reports
3
Brand "Flow Re-Direction Endoluminal", since 2015
PubMed studies
48
Mentioning "Flow Re-Direction Endoluminal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Flow Re-Direction Endoluminal Device (FRED®) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Flow Re-Direction Endoluminal Device (FRED®) SystemPMA supplement
P180027-S013 · Decided Nov 2, 2025 · 178 days after receipt · Normal 180 Day Track No User Fee
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Flow Re-Direction Endoluminal", any status and sponsor, newest update first.
- MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval StudyActive, not recruiting
Microvention-Terumo, Inc.Public (4543.T)
NCT05409989 · 154 participants (planned) · Start Sep 20, 2022 · Primary completion Apr 2027
Device: FRED™ X™ · For: Intracranial Aneurysm
Sites: Hollywood, Florida; Orlando, Florida; Honolulu, Hawaii · 23 sites in all
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Flow Re-Direction Endoluminal", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code OUT
10,961 reports: 7,308 malfunction, 3,152 injury, 499 death
Newest reports for this brand
2032493-2021-00250 · Received Jun 23, 2021 · Event dated Oct 26, 2020
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Visual Impairment
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0108-2026 · Started Sep 5, 2025 · Posted by FDA Oct 10, 2025
Reason given: Flow diverter may have a manufacturing issue related to the tantalum length and/or tantalum attachment pattern, which may lead the device to be incompletely open or not properly apposed to the vessel wall, which may necessitate device recapture and withdrawal of the delivery system and microcatheter together....
Cause as FDA categorized it: Device Design · Device type: Intracranial Aneurysm Flow Diverter (OUT)
Published research
The most relevant PubMed records for "Flow Re-Direction Endoluminal"[tiab]. The summary above synthesizes these.
- Flow re-direction endoluminal device.
Fargen KM, Hoh BL · J Neurosurg · 2014Editorial, Comment
- Efficacy of the Flow Re-direction Endoluminal Device for cerebral aneurysms and causes of failed deployment.
Suyama K, Nakahara I, Matsumoto S, et al. · Neuroradiology · 2022
- A Single Flow Re-direction Endoluminal Device for the Treatment of Large and Giant Anterior Circulation Intracranial Aneurysms.
Choi JH, Sim SY, Shin YS, et al. · Yonsei Med J · 2022
- Abnormal foreshortening of a Flow Re-Direction Endoluminal Device caused by in-stent thrombosis immediately after deployment.
Otsuka T, Izumi T, Nishihori M, et al. · Nagoya J Med Sci · 2022Case Reports
- Flow Diverter Treatment Using a Flow Re-Direction Endoluminal Device for Unruptured Intracranial Vertebral Artery Dissecting Aneurysm: Single-Center Case Series and Technical Considerations.
Suh DC, Song Y, Park SI, et al. · Neurointervention · 2023
- Microsnare Retrieval of a Distorted Flow Re-direction Endoluminal Device (FRED).
Johnson R, Young M, Farhat H · Cureus · 2021Case Reports
- Pipeline Embolization Device and Flow Re-Direction Endoluminal Device for Intracranial Aneurysms: A Comparative Systematic Review and Meta-Analysis Study.
Rashidi F, Habibi MA, Reyhani M, et al. · World Neurosurg · 2024Systematic Review, Meta-Analysis
- Flow Re-direction Endoluminal Device in treatment of cerebral aneurysms: initial experience with short-term follow-up results.
Kocer N, Islak C, Kizilkilic O, et al. · J Neurosurg · 2014
- A rescue treatment to release the twist of a flow re-direction endoluminal device.
Kanazawa R, Uchida T, Higashida T, et al. · Surg Neurol Int · 2024Case Reports
- Treatment strategy for giant thrombosed aneurysm of the basilar artery with associated obstructive hydrocephalus.
Yoshida S, Kamatani K, Maruyama K, et al. · Surg Neurol Int · 2023
- Difference in the cumulative incidence of aneurysmal occlusion by Flow Re-direction Endoluminal Device and Pipeline Embolization Device in the treatment of unruptured internal carotid artery aneurysms: a propensity score-matched cohort study.
Matsukawa H, Uchida K, Rajbhandari S, et al. · Neurosurg Rev · 2023
- The evaluation of the flow re-direction endoluminal device (FRED) for the treatment of selected intracranial aneurysms: a Polish multicenter study.
Jaworski M, Krysiak R, Żykowski J, et al. · Sci Rep · 2025Multicenter Study, Observational Study
Other devices of this type
Also filed under product code OUT.
- Pipeline Flex Embolization Device with Shield TechnologyMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2021
- Pipeline Embolization Devices,pipeline Flex Embolization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2015
- Pipeline Vantage Embolization Device with Shield TechnologyMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2025
- Surpass Streamline Flow DiverterStryker Neurovascular · PMA 2022
- Surpass Elite Flow Diverter SystemStryker Neurovascular · PMA 2024
- FRED X SystemMicroVention, Inc. · PMA 2022
- Surpass Evolve Flow Diverter SystemStryker Neurovascular · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.